Maya sits at her desk with six clinical trial PDFs open across two monitors. She is preparing a launch detail aid for a new therapeutic biologic. Her desk is covered in sticky notes: cross-referencing trial endpoints against Table 3 in the published Phase III manuscript, verifying line numbers for reference callouts, and ensuring every safety disclaimer aligns with the Health Canada-authorized Product Monograph.

Daniel walks over holding a coffee cup, noticing the dozens of open tabs. “Still matching line references manually for the MLR submission binder?” he asks.

Maya sighs. “It takes hours. One wrong page number or an overstated adjective can trigger an MLR rejection or a PAAB revision turn. Someone told me yesterday that new AI systems can draft copy and match references automatically in seconds. If AI can write text, why aren’t we letting it handle this entire process?”

Daniel grins thoughtfully. “AI can scan text and suggest candidate wording at remarkable speed. But AI doesn’t take medical responsibility for patient safety. It doesn’t understand regulatory risk, Product Monograph boundaries, or clinical nuance. AI can assist with tasks across a workflow, but assistance is not replacement.”